Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Non-Current Assets (2020 - 2025)

Bio Essence (BIOE) has 6 years of Non-Current Assets data on record, last reported at $156.0 in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 60.1% year-over-year to $156.0; the TTM value through Sep 2025 reached $156.0, changed N/A, while the annual FY2024 figure was $332.0, 99.84% down from the prior year.
  • Non-Current Assets reached $156.0 in Q3 2025 per BIOE's latest filing, down from $215.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.8 million in Q3 2023 and bottomed at $156.0 in Q3 2025.
  • Average Non-Current Assets over 5 years is $911482.1, with a median of $1.3 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: skyrocketed 30.59% in 2023, then crashed 99.98% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $1.4 million in 2021, then decreased by 6.5% to $1.3 million in 2022, then crashed by 84.5% to $208241.0 in 2023, then crashed by 99.84% to $332.0 in 2024, then plummeted by 53.01% to $156.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $156.0 in Q3 2025, $215.0 in Q2 2025, and $274.0 in Q1 2025.